26 March 2020 (5 years, 7 months, 4 weeks and 2 days)
Confirmed cases
6,398 (10 May 2021)
Active cases
195
Recovered
6,125 (10 May 2021)
Deaths
78 (10 May 2021)
Fatality rate
1.22%
Territories
☁
The first case of theCOVID-19 pandemic in India was reported on 30 January 2020,originating from China. Slowly, the pandemic spread to various states and union territories including the union territory ofAndaman and Nicobar Islands. The first case was recorded in this region on 26 March 2020.[1] The islands have pursued astrategy of zero COVID-19 transmission, which, except for three flareups in August 2020, May 2021, and January 2022, which were swiftly contained, have resulted in no community outbreaks. The islands have successfully managed the outbreaks, and the union territory has the lowest case count of any region of India, both in total cases and infection rate.[2]
As on 23 May 2020, total number of cases in Andaman and Nicobar Islands was 33. There are no active cases, as all 33 have successfully recovered from the virus.[3]
As on 11 June 2020, total number of cases in Andaman and Nicobar Islands was 38. There are 5 active cases and 33 have successfully recovered from the virus.[3]
As on 23 June 2020, total number of cases in Andaman and Nicobar Islands was 50. There are 10 active cases and 40 have successfully recovered from the virus.[3]
As on 26 June 2020, total number of cases in Andaman and Nicobar Islands was 72. There are 29 active cases and 43 have been cured.[3]
As on 29 June 2020, total number of cases in Andaman and Nicobar Islands was 90. There are 45 active cases and 45 have been cured.[3]
As on 1 August 2020, total number of cases in Andaman and Nicobar Islands was 635. There are 402 active cases, 226 have recovered and 7 have died from the virus.[3]
As on 5 August 2020, total number of cases was 928. There are 639 active cases, 277 have been cured and 12 have died from the virus.[3]
As on 8 August 2020, total number of cases was 1222. There are 778 active cases, 425 cures and 19 fatalities.[3]
As on 12 August 2020, total number of cases in the UT was 1900. There are 1050 active cases, 829 have recovered and 21 deaths.[3]
As on 18 August, total number of cases was 2529. There are 1078 active cases, 1421 cures and 30 deaths.[3]
As on 23 August, total number of cases was 2860. There are 864 active cases, 1963 cures and 33 fatalities.[3]
As on 25 August, total number of cases was 2945, including 677 active cases, 2231 recoveries and 37 fatalities.[3]
As on 1 September 2020, total number of cases in Andaman and Nicobar Islands was 3160. There are 400 active cases, 2714 have recovered and 46 have died.[3]
As on 2 September 2020, total number of cases in the UT was 3186. This includes 381 active cases, 2758 recoveries and 47 deaths.[3]
As on 6 September 2020, total number of cases was 3332. This includes 331 active cases, 2951 recoveries and 50 deaths.[3]
As on 7 September 2020, total number of cases was 3359, including 312 active cases, 2997 recoveries and 50 deaths.[3]
As on 11 September 2020, total number of cases was 3494, including 286 active cases, 3157 cures and 51 deaths.[3]
As on 12 September 2020, total number of cases was 3521, including 268 active cases, 3202 cures and 51 deaths.[3]
As on 16 September 2020, total number of cases in the UT was 3593. This includes 196 active cases, 3345 recoveries and 52 deaths.[3]
As on 19 September 2020, total number of cases was 3644, including 156 active cases, 3436 cures and 52 deaths.[3]
As on 20 September 2020, total number of cases was 3651, including 148 active cases, 3451 recoveries and 52 deaths.[3]
As on 21 September 2020, total number of cases was 3673, including 152 active cases, 3469 cures and 52 deaths.[3]
As on 28 September 2020, total number of cases was 3803, including 168 active cases, 3582 recoveries and 53 deaths.[3]
As on 2 October 2020, total number of cases in Andaman and Nicobar Islands was 3858. There are 174 active cases, 3631 have recovered and 53 have died.[3]
As on 3 October 2020, total number of cases was 3868. There are 173 active cases, 3642 have recovered and 53 have died.[3]
As on 4 October 2020, total number of cases was 3884. There are 182 active cases, 3649 cures and 53 fatalities.[3]
As on 5 October 2020, total number of cases was 3899. There are 186 active cases, 3659 cures and 54 deaths.[3]
As on 10 October 2020, total number of cases was 3992, including 193 active cases, 3744 recoveries and 55 deaths.[3]
As on 13 October 2020, total number of cases was 4036, including 199 active cases, 3782 cures and 55 fatalities.[3]
As on 19 October 2020, total number of cases was 4126, including 178 active cases, 3892 cures and 56 deaths.[3]
As on 20 October 2020, total number of cases was 4141, including 183 active cases, 3902 recoveries and 56 deaths.[3]
As on 25 October 2020, total number of cases in the UT was 4245, including 204 active cases, 3983 recoveries and 58 deaths.[3]
As on 27 October 2020, total number of cases was 4274. There are 197 active cases, 4019 have recovered and 58 have died.[3]
As on 30 October 2020, total number of cases was 4317. There are 182 active cases, 4076 have recovered and 59 deaths.[3]
Union Minister for Health & Family Welfare,Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021.
On January 1, 2021, theDrug Controller General of India, approved the emergency or conditional use ofAstraZeneca's COVID-19 vaccineAZD1222 (marketed as Covishield).[5] Covishield is developed by theUniversity of Oxford and its spin-out company,Vaccitech.[6] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months.
On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG.[10] On 21 February 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age.[11][12]
On 21 October 2021, India completed administering of one billion Covid vaccines in the country.[13]
On 8 January 2022, India crossed 1.5 billion Covid vaccines milestone in the country.[14]
On 19 February 2022, India crossed 1.75 billion Covid vaccines milestone in the country.[15]
.jpg)
.svg)